Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 4/20 | 0.59 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HTR7 | P34969 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | LIG1 | P18858 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | RXRG | P48443 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrimidine SCHEMBL27188460 | 0.89 | ADRB2 (0.50) | ADRB2ADRB1MAPK1TP53RAB9A | |
| SCHEMBL7764770 | 0.88 | HPGD (0.55) | ADRB2ADRB1MAPK1HPGDTSHR | |
| SCHEMBL19921086 | 0.87 | ADRB2 (0.48) | ADRB2ADRB1MAPK1TP53RAB9A | |
| SCHEMBL6111939 | 0.86 | GAA (0.50) | ADRB2ADRB1MAPK1TP53RAB9A | |
| SCHEMBL29107282 | 0.86 | SYK (0.54) | ADRB2ADRB1MAPK1TP53RAB9A | |
| SCHEMBL5611931 | 0.86 | ADRB2 (0.47) | ADRB2ADRB1MAPK1TP53RAB9A | |
| SCHEMBL11971449 | 0.85 | MAPK1 (0.53) | ADRB2ADRB1MAPK1TP53RAB9A | |
| SCHEMBL9431758 | 0.84 | RXRA (0.61) | ADRB2ADRB1MAPK1RAB9AHTT | |
| SCHEMBL6665177 | 0.83 | SYK (0.56) | ADRB2ADRB1MAPK1TP53HTT | |
| SCHEMBL22085950 | 0.83 | ADRB2 (0.44) | ADRB2ADRB1MAPK1HTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117677671-A | Curable resin composition, varnish, prepreg, and cured product | 本州化学工业株式会社 | 2024-03-08 | — | — | CN | claimed |
| CN-115010613-A | Allyl-containing diamine monomer, crosslinkable polyetherimide polymer, crosslinked polyetherimide film and preparation method thereof | 大连理工大学盘锦产业技术研究院 | 2022-09-06 | — | — | CN | claimed |
| CN-105188852-A | Processes for making magnolol derivatives | COLGATE PALMOLIVE CO | 2015-12-23 | — | — | CN | claimed |
| EP-3768763-B1 | SILICONE POLYMER AND COMPOSITION COMPRISING THE SAME | MOMENTIVE PERFORMANCE MAT INC (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4719750-A1 | EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719751-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719753-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4683790-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025109468-A1 | EMBEDDED CONTACT LENS WITH A HIGH REFRACTIVE INDEX INSERT THEREIN | ALCON INC. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2024246822-A1 | METHOD FOR MAKING EMBEDDED SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024246819-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2024-12-05 | — | — | WO | disclosed |
| CN-1829726-A | Metathesis catalysts | BOEHRINGER INGELHEIM INT (DE) | 2006-09-06 | — | — | CN | disclosed |
| EP-1654266-A1 | NOVEL METATHESIS CATALYSTS | Boehringer Ingelheim International GmbH (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-20050049417-A1 | Metathesis catalysts | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-03-03 | — | — | US | disclosed |
| WO-2005016944-A1 | NOVEL METATHESIS CATALYSTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004024684-A2 | ENANTIOSELECTIVE AMINATION AND ETHERIFICATION | YALE UNIVERSITY (US) | 2004-03-25 | — | — | WO | disclosed |
| EP-1248109-A1 | Enantiomeric excess determination using a liquid crystal material | Rijksuniversiteit te Groningen (NL) | 2002-10-09 | — | — | EP | disclosed |
| EP-0524409-A1 | Thermosetting bismaleinimide molding masses | BASF Aktiengesellschaft (DE) | 1993-01-27 | — | — | EP | disclosed |
| US-5143969-A | Composites with reinforcing fibers | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-01 | — | — | US | disclosed |
| EP-0361500-A2 | Thermosensitive recording materials | MITSUBISHI PAPER MILLS, LTD. (JP) | 1990-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049417-A1 | Metathesis catalysts | CYP1B1, MSMO1, CYP1A1 | ADRB2 3774/4885ADRB1 3613/4885MAPK1 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.